Boothbay Fund Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Boothbay Fund Management's EW Position: Q3 2026 in Review
Boothbay Fund Management opened a new position in Edwards Lifesciences (EW) in Q3 2026: 10,494 shares worth $906K. The stake represents 0.01% of the portfolio and ranks #1023 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in EW as recently as Q1 2026.
Boothbay Fund Management first reported a position in EW in Q4 2016 and has held it in 17 quarters since. The position peaked at $1.14M in Q1 2024. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Boothbay Fund Management held 10,494 shares of Edwards Lifesciences worth $906K as of Q3 2026.
- Edwards Lifesciences was a new Boothbay Fund Management position in Q3 2026.
- Edwards Lifesciences made up 0.01% of Boothbay Fund Management's portfolio in Q3 2026, its #1023 holding.
- Boothbay Fund Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 17 quarters since.
- Boothbay Fund Management's Edwards Lifesciences position peaked at $1.14M in Q1 2024.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.